Package 69102-319-02

{"route": ["ORAL"], "spl_id": "dc973c32-37d9-437d-8053-cbf96b9f20cd", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0369102150069", "0369102319015", "0369102320011", "0369102301010"], "unii": ["U3H27498KS"], "rxcui": ["198427", "198428", "198429", "282401", "751139", "751563", "753451", "2001506", "2001508", "2003796", "2003797", "2003798", "2003799", "2003801"], "spl_set_id": ["7ad18b68-ba16-4810-9c3e-27fa970454e8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["OWP Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69102-319-01)", "package_ndc": "69102-319-01", "marketing_start_date": "20180310"}, {"sample": false, "description": "2500 TABLET in 1 BOTTLE (69102-319-02)", "package_ndc": "69102-319-02", "marketing_start_date": "20180310"}], "brand_name": "SUBVENITE", "product_id": "69102-319_dc973c32-37d9-437d-8053-cbf96b9f20cd", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "69102-319", "generic_name": "LAMOTRIGINE", "labeler_name": "OWP Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SUBVENITE", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "100 mg/1"}], "application_number": "ANDA078947", "marketing_category": "ANDA", "marketing_start_date": "20180310", "listing_expiration_date": "20261231"}